[PDF][PDF] Oncolytic Viruses, Bi-specific T Cell Engagers and CAR-T Cells: A Promising Triple Combination Therapy for Pancreatic Ductal Adenocarcinomas

G Savage - UJEMI PEARLS, 2019 - jemi.microbiology.ubc.ca
… the T cell triggers a targeted release of cytotoxic granules into … -T cells and target them to
pancreatic cancer cells in order to … late, research into liquid biopsies and molecular diagnostics …

Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors

M Wei, S Zuo, Z Chen, P Qian, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
… primary T cell activation and T cell-mediated cytotoxicity … Fajardo et al. engineered an
oncolytic adenovirus, ICOVIR-… the efficacy of OV-BiTE in cancer biopsies. However, the lack of a …

Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer

Q Wang, X Ma, H Wu, C Zhao, J Chen, R Li… - …, 2022 - Taylor & Francis
cancer (OC) is related to the action of infiltrating cytotoxic T … In this study, we tested the
hypothesis that bispecific T-cell … in the biopsy of all tested patients tested positive for PD1 …

[HTML][HTML] Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy

C Groeneveldt, P Kinderman… - … of Cancer, 2020 - ncbi.nlm.nih.gov
T-cell-engaging bispecific antibodies (bsAbs) are emerging as a … in xenograft models and
an oncolytic adenovirus encoding a CD3-… So-called “on-target, off-tumor toxicity” might limit the …

[HTML][HTML] Revolutionizing cancer treatment: the power of bi-and tri-specific T-cell engagers in oncolytic virotherapy

AZ Mehrabadi, M Tat, AG Alvanegh… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
… ) presentation, T-cell proliferation, activation, and cytotoxicity against … presentation across
multiple biopsies. This observation … oncolytic adenovirus, EnAd, to express TAM-targeting T cell

[HTML][HTML] Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy

D Ravirala, B Mistretta, PH Gunaratne… - … of cancer, 2021 - ncbi.nlm.nih.gov
… an oncolytic vaccinia virus with a secretory bispecific T-cell … the signature NK and T cell
activation and cytotoxic genes by … risk of potential on-target off-tumor toxicity. Delivery of BiCEP …

Current development in adenoviral vectors for cancer immunotherapy

GWG Biegert, AR Shaw, M Suzuki - Molecular Therapy-Oncolytics, 2021 - cell.com
… The 24-bp deletion present in some oncolytic adenovirus … is the ultimate goal of Ad gene
therapies for cancer. However… required to activate T cell function via the T cell receptor (TCR). (D…

Solid tumor immunotherapy with T cell engager‐armed oncolytic viruses

EM Scott, MR Duffy, JD Freedman… - Macromolecular …, 2018 - Wiley Online Library
toxicity at the lowest dose of 0.2 × 10 9 T cells infused, with subsequent examination of patients'
liver biopsies revealing CAIX expression … ” oncolytic adenoviruses targeting both cancer

Targeted BiTE expression by an oncolytic vector augments therapeutic efficacy against solid tumors

T Speck, JPW Heidbuechel, R Veinalde, D Jaeger… - Clinical Cancer …, 2018 - AACR
… that oncolytic measles viruses encoding bispecific T-cell … local BiTE-mediated cytotoxicity
and oncolytic immune modulation would … , target-specific T-cell activation and induction of T-cell

Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data

S Pesonen, L Kangasniemi… - Molecular …, 2011 - ACS Publications
adenovirus-specific memory CD4+ and cytotoxic CD8+ T cell (CTL) responses. Conserved
epitopes within the adenovirus capsid (mostly hexon) are the main targets for … tumor biopsies